Ginkgo biloba extract: Mechanisms and clinical indications
2000/05/01 by Bruce J. Diamond, Samuel C. Shiflett, Nancy Feiwel +4 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Adverse effect #Coenzyme Q10 studies and effects #Dementia #Disease #Ginkgo biloba #Ginkgo biloba and Cashew Applications #Internal medicine #Medicine #Neurological Disease Mechanisms and Treatments #Pharmacology #Stroke (engine) #Vascular dementia
paper · doi:10.1016/s0003-9993(00)90052-2
openalex publication_date 2000/05/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Cited by
- Interactions Between Herbal Medicines and Prescribed Drugs
- Liquid chromatography/electrospray tandem mass spectrometry of terpenoid lactones in Ginkgo biloba. [europepmc]
- Effect of Ginkgo biloba (EGb 761) on treadmill walking time among adults with peripheral artery disease: a randomized clinical trial. [europepmc]
- Promoting successful cognitive aging: a comprehensive review. [europepmc]
- Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. [europepmc]
- Effect of Ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia reperfusion rats. [europepmc]
- The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. [europepmc]
- Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study. [europepmc]
- Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies. [europepmc]
- Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview. [europepmc]
- Systemic exposure to Ginkgo biloba extract in male F344/NCrl rats: Relevance to humans. [europepmc]
- Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. [europepmc]
- Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma. [europepmc]
- Properties of Ginkgo biloba L.: Antioxidant Characterization, Antimicrobial Activities, and Genomic MicroRNA Based Marker Fingerprints. [europepmc]
- Herbal Medicines in Glaucoma Treatment. [europepmc]
- Natural products: potential treatments for cisplatin-induced nephrotoxicity. [europepmc]
- Military traumatic brain injury: a challenge straddling neurology and psychiatry. [europepmc]
- The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment. [europepmc]
- Staphyloxanthin as a Potential Novel Target for Deciphering Promising Anti- Staphylococcus aureus Agents. [europepmc]
- Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity. [europepmc]
- Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. [europepmc]
- Current Naturopathy to Combat Alzheimer's Disease. [europepmc]
- Medicinal herbs and multiple sclerosis: Overview on the hard balance between new therapeutic strategy and occupational health risk. [europepmc]
- Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers. [europepmc]
- A bibliometric and thematic analysis of the trends in the research on ginkgo biloba extract from 1985 to 2022. [europepmc]
- Comprehensive Ethnopharmacological Analysis of Medicinal Plants in the UAE: Lawsonia inermis , Nigella sativa , Ziziphus spina-christi , Allium cepa , Allium sativum , Cymbopogon schoenanthus , Matricaria aurea , Phoenix dactylifera , Portulaca oleracea , Reichardia tingitana , Salvadora persica , Solanum lycopersicum , Trigonella foenum-graecum , Withania somnifera , and Ziziphus lotus . [europepmc]